GENMAB A/S earnings
Annual earnings per share (USD per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $0.83 | $0.84 | 2026-06-19T06:01:54Z |
| 2025 | 2025-03-31 | $3.05 | $3.06 | 2026-06-19T06:01:54Z |
Revenue & profit (USD)
| Concept | 2026 | 2025 | 2025 |
|---|---|---|---|
| Revenue | $896.0M | — | $715.0M |
| Profit for the year | $53.0M | — | $195.0M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in GENMAB A/S's ESEF annual reports (source:
filings.xbrl.org).
Figures are in USD, as reported. Not investment advice.